Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations

References

• 1  Fosbol EL, Gislason GH, Jacobsen S et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol. Drug Saf.17(8),822–833 (2008).
  MedlineGoogle Scholar
• 2  Motola D, Vaccheri A, Silvani MC et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur. J. Clin. Pharmacol.60(10),731–738 (2004).
  MedlineGoogle Scholar
• 3  Kowalski ML, Makowska JS, Blanca M et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy66(7),818–829 (2011).
  Medline CASGoogle Scholar
• 4  Szczeklik A, Nizankowska E, Sanak M. Hypersensitivity to aspirin and non-steroidal antiinflammatory drugs. In: Midleton´s Allergy, Principles and Practice. Adkinson Nf BB, Busse WW, Holgate S, Lemanske RF, Simons FE (Eds). Mosby, PA, USA, 1227–1243 (2009).
  Google Scholar
• 5  Dona I, Blanca-Lopez N, Cornejo-Garcia JA et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin. Exp. Allergy41(1),86–95 (2011).
  Medline CASGoogle Scholar
• 6  Dona I, Blanca-Lopez N, Torres MJ et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J. Investig. Allergol. Clin. Immunol.22(5),363–371 (2012).
  Medline CASGoogle Scholar
• 7  Cornejo-Garcia JA, Blanca-Lopez N, Dona I et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr. Drug Metab.10(9),971–980 (2009).
  Medline CASGoogle Scholar
• 8  Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J. Allergy Clin. Immunol.127(3 Suppl.),S67–S73 (2011).
  Medline CASGoogle Scholar
• 9  Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J.1(5949),67–69 (1975).
  Medline CASGoogle Scholar
• 10  Christie PE, Tagari P, Ford-Hutchinson AW et al. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am. Rev. Respir. Dis.146(6),1531–1534 (1992).
  Medline CASGoogle Scholar
• 11  Gaber F, Daham K, Higashi A et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax63(12),1076–1082 (2008).
  Medline CASGoogle Scholar
• 12  Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am. J. Respir. Crit. Care Med.166(3),301–306 (2002).
  MedlineGoogle Scholar
• 13  Cowburn AS, Sladek K, Soja J et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Investig.101(4),834–846 (1998).
  Medline CASGoogle Scholar
• 14  Sanak M, Kielbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin. Exp. Allergy34(12),1899–1904 (2004).
  Medline CASGoogle Scholar
• 15  Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J. Allergy Clin. Immunol.112(5),995–1001 (2003).
  Medline CASGoogle Scholar
• 16  Szczeklik A, Sladek K, Dworski R et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am. J. Respir. Crit. Care Med.154(6 Pt 1),1608–1614 (1996).
  Medline CASGoogle Scholar
• 17  Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J. Allergy Clin. Immunol.113(4),771–775 (2004).
  Medline CASGoogle Scholar
• 18  Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J. Allergy Clin. Immunol.123(1),174–178 (2009).
  Medline CASGoogle Scholar
• 19  Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Cmiel A, Szczeklik A. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax63(1),27–34 (2008).
  Medline CASGoogle Scholar
• 20  Sanak M, Gielicz A, Bochenek G, Kaszuba M, Nizankowska-Mogilnicka E, Szczeklik A. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J. Allergy Clin. Immunol.127(5),1141–1147.e1142 (2011).
  Medline CASGoogle Scholar
• 21  Higashi N, Mita H, Ono E et al. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J. Allergy Clin. Immunol.125(5),1084–1091.e1086 (2010).
  Medline CASGoogle Scholar
• 22  Gray PA, Warner TD, Vojnovic I et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Br. J. Pharmacol.137(7),1031–1038 (2002).
  Medline CASGoogle Scholar
• 23  Duroudier NP, Tulah AS, Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy64(6),823–839 (2009).
  Medline CASGoogle Scholar
• 24  Kim SH, Ye YM, Palikhe NS, Kim JE, Park HS. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol.10(4),280–290 (2010).
  MedlineGoogle Scholar
• 25  Choi JH, Park HS, Oh HB et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum. Genet.114(4),337–344 (2004).
  Medline CASGoogle Scholar
• 26  Jinnai N, Sakagami T, Sekigawa T et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum. Mol. Genet.13(24),3203–3217 (2004).
  Medline CASGoogle Scholar
• 27  Kim SH, Choi JH, Holloway JW et al. Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. J. Korean Med. Sci.20(6),926–931 (2005).
  Medline CASGoogle Scholar
• 28  Kim SH, Oh JM, Kim YS et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin. Exp. Allergy36(4),433–439 (2006).
  Medline CASGoogle Scholar
• 29  Kim SH, Yang EM, Park HJ, Ye YM, Lee HY, Park HS. Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity. J. Clin. Immunol.27(6),613–619 (2007).
  MedlineGoogle Scholar
• 30  Park JS, Chang HS, Park CS et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet. Genomics15(7),483–492 (2005).
  Medline CASGoogle Scholar
• 31  Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am. J. Respir. Cell Mol. Biol.23(3),290–296 (2000).
  Medline CASGoogle Scholar
• 32  Cornejo-Garcia JA, Jagemann LR, Blanca-Lopez N et al. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria. Clin. Exp. Allergy42(12),1772–1781 (2012).
  Medline CASGoogle Scholar
• 33  Agundez JA, Ayuso P, Cornejo-Garcia JA et al. The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PLoS ONE7(11),e47571 (2012).
  Medline CASGoogle Scholar
• 34  Kim JH, Park BL, Cheong HS et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS ONE5(11),e13818 (2010).
  MedlineGoogle Scholar
• 35  Park BL, Kim TH, Kim JH et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum. Genet.132(3),313–321 (2013).
  Medline CASGoogle Scholar
• 36  Blanca-Lopez N, J Torres M, Dona I et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin. Exp. Allergy43(1),85–91 (2013).
  Medline CASGoogle Scholar
• 37  Han Y, Kaeser PS, Sudhof TC, Schneggenburger R. RIM determines Ca²⁺ channel density and vesicle docking at the presynaptic active zone. Neuron69(2),304–316 (2011).
  Medline CASGoogle Scholar
• 38  Weiss N, Sandoval A, Kyonaka S, Felix R, Mori Y, De Waard M. Rim1 modulates direct G-protein regulation of Ca(v)2.2 channels. Pflugers Arch. Eur. J. Physiol.461(4),447–459 (2011).
  Medline CASGoogle Scholar
• 39  Hui Y, Funk CD. Cysteinyl leukotriene receptors. Biochem. Pharmacol.64(11),1549–1557 (2002).
  Medline CASGoogle Scholar
• 40  Thompson MD, Takasaki J, Capra V et al. G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective. Mol. Diagn. Ther.10(6),353–366 (2006).
  Medline CASGoogle Scholar
• 41  Fujishima H, Sanchez Mejia RO, Bingham CO 3rd et al. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl Acad. Sci. USA96(9),4803–4807 (1999).
  Medline CASGoogle Scholar
• 42  Franco R, Pacheco R, Lluis C, Ahern GP, O’Connell PJ. The emergence of neurotransmitters as immune modulators. Trends Immunol.28(9),400–407 (2007).
  Medline CASGoogle Scholar
• 43  Mikami N, Fukada S, Yamamoto H, Tsujikawa K. Neuronal derivative mediators that regulate cutaneous inflammations. Crit. Rev. Immunol.32(4),307–320 (2012).
  Medline CASGoogle Scholar
• 44  Chabardes D, Imbert-Teboul M, Elalouf JM. Functional properties of Ca²⁺-inhibitable type 5 and type 6 adenylyl cyclases and role of Ca²⁺ increase in the inhibition of intracellular cAMP content. Cell. Signal.11(9),651–663 (1999).
  Medline CASGoogle Scholar
• 45  Piazzon N, Maisonneuve C, Guilleret I, Rotman S, Constam DB. Bicc1 links the regulation of cAMP signaling in polycystic kidneys to microRNA-induced gene silencing. J. Mol. Cell Biol.4(6),398–408 (2012).
  Medline CASGoogle Scholar
• 46  Wymann MP, Schneiter R. Lipid signalling in disease. Nat. Rev. Mol. Cell Biol.9(2),162–176 (2008).
  Medline CASGoogle Scholar
• 47  Serra-Pages M, Olivera A, Torres R, Picado C, De Mora F, Rivera J. E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling. J. Leukoc. Biol.92(6),1155–1165 (2012).
  Medline CASGoogle Scholar
• 48  Weston MC, Peachell PT. Regulation of human mast cell and basophil function by cAMP. Gen. Pharmacol.31(5),715–719 (1998).
  Medline CASGoogle Scholar
• 49  Wakoh T, Uekawa N, Terauchi K et al. Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression. Biochem. Biophys. Res. Commun.380(4),807–812 (2009).
  Medline CASGoogle Scholar
• 50  Kopp E, Ghosh S. Inhibition of NF-kappaB by sodium salicylate and aspirin. Science265(5174),956–959 (1994).
  Medline CASGoogle Scholar
• 51  Stark LA, Din FV, Zwacka RM, Dunlop MG. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J.15(7),1273–1275 (2001).
  Medline CASGoogle Scholar
• 52  Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ. Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells. Int. J. Oncol.34(3),597–608 (2009).
  Medline CASGoogle Scholar
• 53  Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic Acids Res.40(13),5795–5818 (2012).
  Medline CASGoogle Scholar
• 54  Klein HL. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair7(5),686–693 (2008).
  Medline CASGoogle Scholar
• 55  Fornander LH, Frykholm K, Reymer A, Renodon-Corniere A, Takahashi M, Norden B. Ca²⁺ improves organization of single-stranded DNA bases in human Rad51 filament, explaining stimulatory effect on gene recombination. Nucleic Acids Res.40(11),4904–4913 (2012).
  Medline CASGoogle Scholar
• 56  Hirose K, Inukai T, Kikuchi J et al. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19). Blood116(6),962–970 (2010).
  Medline CASGoogle Scholar
• 57  Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab.4(1),25–36 (2006).
  Medline CASGoogle Scholar
• 58  Xie G, Wong CC, Cheng KW, Huang L, Constantinides PP, Rigas B. Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety. Br. J. Pharmacol.167(1),222–232 (2012).
  Medline CASGoogle Scholar
• 59  Zhu Y, Zhang QY. Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine. J. Pharmacol. Exp. Ther.343(2),362–370 (2012).
  Medline CASGoogle Scholar
• 60  Yang J, Dong H, Hammock BD. Profiling the regulatory lipids: another systemic way to unveil the biological mystery. Curr. Opin. Lipidol.22(3),197–203 (2011).
  Medline CASGoogle Scholar
• 61  Matsuo N, Tanaka S, Gordon MK, Koch M, Yoshioka H, Ramirez F. CREB-AP1 protein complexes regulate transcription of the collagen XXIV gene (Col24a1) in osteoblasts. J. Biol. Chem.281(9),5445–5452 (2006).
  Medline CASGoogle Scholar
• 62  Chiappara G, Chanez P, Bruno A et al. Variable p-CREB expression depicts different asthma phenotypes. Allergy62(7),787–794 (2007).
  Medline CASGoogle Scholar
• 63  Agrawal B, Krantz MJ, Parker J, Longenecker BM. Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res.58(18),4079–4081 (1998).
  Medline CASGoogle Scholar
• 64  Cloosen S, Thio M, Vanclee A et al. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. Int. Immunol.16(11),1561–1571 (2004).
  Medline CASGoogle Scholar
• 65  Leong CF, Raudhawati O, Cheong SK, Sivagengei K, Noor Hamidah H. Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts. Pathology35(5),422–427 (2003).
  Medline CASGoogle Scholar
• 66  Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell7(2),167–178 (2005).
  Medline CASGoogle Scholar
• 67  Rahn JJ, Shen Q, Mah BK, Hugh JC. MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. J. Biol. Chem.279(28),29386–29390 (2004).
  Medline CASGoogle Scholar
• 68  Zhao J, Wei J, Mialki RK et al. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat. Immunol.13(7),651–658 (2012).
  Medline CASGoogle Scholar
• 69  Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet.11(6),415–425 (2010).
  Medline CASGoogle Scholar
• 70  Spencer C, Hechter E, Vukcevic D, Donnelly P. Quantifying the underestimation of relative risks from genome-wide association studies. PLoS Genet.7(3),e1001337 (2011).
  Medline CASGoogle Scholar
• 71  Park JH, Wacholder S, Gail MH et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet.42(7),570–575 (2010).
  Medline CASGoogle Scholar
• 72  Genomes Project C, Abecasis GR, Altshuler D et al. A map of human genome variation from population-scale sequencing. Nature467(7319),1061–1073 (2010).
  MedlineGoogle Scholar